![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|18|29|4475-4484
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.18, Iss.29, 2012-10, pp. : 4475-4484
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Goertsches Robert H Hecker Michael Koczan Dirk Serrano-Fernandez Pablo Moeller Steffen Thiesen Hans-Juergen Zettl Uwe K
Pharmacogenomics, Vol. 11, Iss. 2, 2010-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
IFN- treatment cost driver in relapsing-remitting MS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 458, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
IFN- treatment cost driver in relapsing-remitting MS
Inpharma, Vol. 1, Iss. 1448, 2004-01 ,pp. :